Kinetic model for gentamicin dosing with the use of individual patient parameters
- PMID: 837654
- DOI: 10.1002/cpt1977213362
Kinetic model for gentamicin dosing with the use of individual patient parameters
Abstract
Multiple-infusion dosing regimens for gentamicin were established for 84 patients with the use of individually calculated values of elimination kinetic parameters. Serum level-time data obtained after a single infusion were used to determine the patient's gentamicin half-life (t 1/2) and distribution volume. Patients with serum creatinine (Cr) less than 1.2 mg per 100 ml had t 1/2 (mean, 2.25 hr) and total body clearances (mean, 0.082 L/hr/kg) significantly different from those with Cr greater than or equal to 1.2 mg/100 ml (means, 5.3 and 0.039, respectively). Distribution volumes were not significantly different (means, 0.22 and 0.21 L/kg, respectively). Calculations of dosing intervals and infusion rates, based on each patient's kinetic parameters and desired steady-state peaks and nadirs, assumed a one-compartment model with first-order elimination and 1-hr constant-rate input at fixed intervals. Follow-up steady-state peak and nadir levels were measured in 63 of the regimens. Differences between predicted and measured peak levels averaged --0.05 mug/ml with 60% of the measured values falling within 1 mug/ml of that predicted. Predicted-measured nadir differences averaged --0.62 mug/ml (significantly different from zero) indicating slight bias in the model. Fifty-six percent of these nadirs were within 1 mug/ml of that predicted.
Similar articles
-
A model for dosing gentamicin in children and adolescents that adjusts for tissue accumulation with continuous dosing.Clin Pharmacokinet. 1980 May-Jun;5(3):295-306. doi: 10.2165/00003088-198005030-00007. Clin Pharmacokinet. 1980. PMID: 7389237
-
Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.Am J Hosp Pharm. 1980 Aug;37(8):1077-83. Am J Hosp Pharm. 1980. PMID: 7405935
-
Rapid gentamicin elimination in obstetric patients.Obstet Gynecol. 1980 Nov;56(5):559-64. Obstet Gynecol. 1980. PMID: 7432725
-
Pharmacokinetics of gentamicin in children and adults.J Infect Dis. 1975 Dec;132(6):637-51. doi: 10.1093/infdis/132.6.637. J Infect Dis. 1975. PMID: 1202109
-
Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations.Antimicrob Agents Chemother. 1982 Mar;21(3):407-11. doi: 10.1128/AAC.21.3.407. Antimicrob Agents Chemother. 1982. PMID: 7103444 Free PMC article.
Cited by
-
Pharmacokinetics of vancomycin in adult cystic fibrosis patients.Antimicrob Agents Chemother. 1996 Jan;40(1):186-90. doi: 10.1128/AAC.40.1.186. Antimicrob Agents Chemother. 1996. PMID: 8787903 Free PMC article. Clinical Trial.
-
Easier monitoring of aminoglycoside therapy with once-daily dosing schedules.Eur J Clin Microbiol Infect Dis. 1995 Jun;14(6):531-5. doi: 10.1007/BF02113434. Eur J Clin Microbiol Infect Dis. 1995. PMID: 7588829 Clinical Trial.
-
Gentamicin pharmacokinetic changes in induced acute canine nephrotoxic glomerulonephritis.Antimicrob Agents Chemother. 1981 Sep;20(3):387-92. doi: 10.1128/AAC.20.3.387. Antimicrob Agents Chemother. 1981. PMID: 7305324 Free PMC article.
-
Extended-interval gentamicin administration in neonates: a simplified approach.J Perinatol. 2016 Aug;36(8):660-5. doi: 10.1038/jp.2016.37. Epub 2016 Mar 17. J Perinatol. 2016. PMID: 26986995 Clinical Trial.
-
Implementation and evaluation of control strategies for individualizing dosage regimens, with application to the aminoglycoside antibiotics.J Pharmacokinet Biopharm. 1986 Oct;14(5):523-37. doi: 10.1007/BF01059659. J Pharmacokinet Biopharm. 1986. PMID: 3806374